Funding Opportunities

Request for Applications (RFA)—proposed FY 2026 initiative Contacts: Marina Protopopova marina.protopopova@nih.gov Kristen Porter kristen.porter@nih.gov Description: This NOFO will utilize a biphasic, milestone-driven award. The first phase will support research that has demonstrated significant preliminary data but has not advanced to the level of clinical translation. The second phase will support research that is in the final states of preclinical development with potential for IND submission. Samples from clinical trials supported elsewhere and animal research will be supported. Clinical trials are not allowed.

GHC welcomes young professionals from Burundi, Ethiopia, Ghana, Kenya, Liberia, Malawi, Nigeria, Rwanda, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe to apply for paid 13 month fellowships with health organizations in Malawi, Rwanda, Uganda, and Zambia. Jan 10 2024 deadline (so mark calendars for 2025) applyinfo@ghcorps.org

Apply for funding to support exceptional early to mid-career African researchers to conduct excellent global health research across sub-Saharan Africa (SSA). Opens Jan 24 2024; closes April 24, 2024

Our anticipated timeline is: Concept Proposal due: December 2, 2024 Notification of Outcome: December 20, 2024

This cross consortium supplemental funding will support cross-cutting research activities and develop or strengthen collaborations across RePORT scientists. Investigators and study populations must derive from at least two RePORT country networks. Submission Deadline Friday, June 21 2024

Contact: Roger Ptak Roger.Ptak@nih.gov Objective: This new initiative aims to support investigator-led, multidisciplinary research to define how HIV-driven alterations to immunometabolism affect immune cell regulation, cell-cell interactions, response to treatment, and, ultimately, tuberculosis (TB) and hepatitis B virus (HBV) progression. Elucidating and subsequently probing such mechanisms will lead to identification of candidate biomarkers of disease progression and potential targets for immune-modulatory treatment (i.e., host-directed therapy) to decrease TB and HBV risk in people living with HIV. Description: This initiative will advance laboratory-based research to elucidate immunometabolic pathways and mechanisms that can be exploited for new therapeutic and diagnostic strategies.

Please note that some of the SMART4TB sites have already been supported by EDCTP in the past, Mozambique INS for example.

(Bookmark for Feb 2025) Long-Term Research Fellowships European Respiratory Society (ERS) Long-Term Research Fellowships support researchers and clinicians in the early stages of their careers to carry out basic, translational or clinical research projects lasting between 6–12 months. Fellowship recipients conduct projects at research institutions outside of their home country, enabling fellows to access and learn research techniques that are not available at their home institute. Long-term fellowships are awarded annually based on scientific merit as well as the skills and experience that fellows can bring to the host centre.

L’Initiative encourages the implementation of projects that involve national pandemic response programs, the research community, civil society, and the private sector. The main project initiator must be a legal entity with a board of directors/executive committee and head office registered in an eligible country or in France.

Usually application due in November; application opens in August. The Global Health Fellowship Program is a 12-month clinical research training program for post-doctorate trainees and doctoral students in the health professions, sponsored by the NIH’s Fogarty International Center (FIC) in partnership with several NIH Institutes and Centers.

US Citizens or LMIC postdocs - Please see full details on website

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply. Eligibility status of applicant organizations will be determined by the World Bank Classification list at the time of application submission. Please visit website for more information - deadline appears to be August 02, 2024

Please note that the submission of projects are allowed for French Research teams. For non-French researchers, they should be presenting their research projects in collaboration with some French research team. All calls and their requirements are mentioned on the ANRS website. It is easier to get this funding for ESI who contribute to some ANRS studies in their respective countries…

Contact: Robert Mahon Robert.Mahon@nih.gov Objective: The scientific objectives of this new initiative are to 1) better understand the types and pathogenesis of long-term lung damage resulting from pulmonary tuberculosis (TB) and the role of the host immune response, and 2) identify ways to mitigate lung damage during TB treatment through host-directed therapy. There is no set-aside funding for this NOSI.

Contacts: Marina Protopopova marina.protopopova@nih.gov Kristen Porter kristen.porter@nih.gov Objective: The objectives of this NOSI are to 1) support the development of innovative sustained release (SR)/long-acting (LA) products and strategies that provide a minimum of 3 months of HIV treatment or prevention and 2) develop SR/LA strategies for a minimum of once-a-month treatment of tuberculosis and hepatitis B in people living with HIV, and a once-a-month treatment of hepatitis C with the ultimate goal to develop a one-shot cure of hepatitis C. Description: This initiative is focused on the development of innovative technologies to enable intermittent dosing to treat and prevent HIV and HIV co-infections. Use of samples from clinical trials supported elsewhere and animal research including nonhuman primates may be supported. Clinical trials are not allowed. There is no set-aside funding for this NOSI.

May 15, 2024 In this spirit, we invite applications for the Pivot Fellowship program which will support researchers who have a strong track record of success and achievement in their current field, and a deep interest, curiosity and drive to make contributions to a new discipline. The fellowship will enable today’s brightest minds to apply their talent and expertise to a new field and will consist of one training year where the fellow will be embedded in a lab of a mentor to learn the new discipline and its culture. Mentorship and support are essential for learning a new discipline and culture. In addition to the qualifications and potential of the applicant, the suitability of the mentor and the environment for mentorship will be strongly considered in the application process.

Post-doctoral Fellowship in TB Immunology Research - Due March 1 2024.

The purpose of this notice of funding opportunity (NOFO) is to understand the critical drivers of tuberculosis (TB) transmission at the individual and population levels in high-burden settings; to develop effective methods to measure rates of TB transmission that rely on an increased understanding of the biomedical basis of transmission and related risk factors; and assess potential interventions, including low-cost and low-tech options, to prevent TB transmission and detect infectious TB.

UJMT LAUNCH: Building Research Capacity through Mentored Training Applications for the 2025-2026 UJMT LAUNCH cohort are due October 1.

Offers funding and support across all academic disciplines and industrial areas from the medical and biological sciences to astronomy, physics, chemistry and engineering, social sciences, economics, environmental sciences, and the arts and humanities.

The TB REACH Wave 11 call for proposals is focused on innovative approaches to integrate TB service delivery with lung health at the primary and community level of the health systems.

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.